EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The activity of the EMT suppressor GRHL2 is regulated by SUMOylation

Sonja Santjer, Yang Xu, Sabine Riethdorf, Gerhard Schön, Johanna Neu, Klaus Pantel, Volker Assmann

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Sonja Santjer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Sumoylation, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Damp Stiftung, Universitätsklinikum Hamburg-Eppendorf.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The developmental transcription factor grainyhead-like 2 (GRHL2) has been attributed both tumor-suppressive and protumorigenic functions in a large variety of human cancers. Despite its fundamental role in cancer development and progression, mechanisms modulating expression or activity of GRHL2 in cancer cells still remain elusive. We identified several components of the SUMOylation machinery as candidate GRHL2 interactors using a yeast two-hybrid screening approach and a single major GRHL2 SUMOylation site at lysine residue 159. SUMOylation of GRHL2 at lysine 159 enhances its transcriptional activity and was found to be stimulated by phosphorylation of GRHL2 at threonine 164 by p38α/β MAPKs or by interaction with members of the PIAS family of SUMO E3 ligases. Additionally, structural analysis identified GRHL2 as an intrinsically disordered protein with a high propensity to misfold and to form aggresome-like structures in the nucleus, resulting in repression of GRHL2 transcriptional activity. Results obtained by immunohistochemical analysis of GRHL2 expression in primary breast cancers support an important role of GRHL2 subnuclear compartmentalization in breast carcinogenesis. Taken together, our results provide new insights into complex regulatory mechanisms governing GRHL2 activity in cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsDNA-Binding ProteinsSumoylationBreast NeoplasmsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansFemalePhosphorylationCell Line, TumorHEK293 Cells

Stichwörter der Autor:innen

Epithelial-mesenchymal transition (EMT)SUMOylationbreast cancerinvasionmetastasisoncogeneposttranslational modification (PTM)transcription factor

Substanzen

Transcription FactorsGRHL2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: v.assmann@uke.de.

Förderung

  • Damp Stiftung
  • Universitätsklinikum Hamburg-Eppendorf

Zitieren

APA

Santjer, S., Xu, Y., Riethdorf, S., Schön, G., Neu, J., Pantel, K., & Assmann, V. (2025). The activity of the EMT suppressor GRHL2 is regulated by SUMOylation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110662

Vancouver

Santjer S, Xu Y, Riethdorf S, Schön G, Neu J, Pantel K, et al. The activity of the EMT suppressor GRHL2 is regulated by SUMOylation. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110662

BibTeX
@article{Santjer2025,
  author = {Santjer, Sonja and Xu, Yang and Riethdorf, Sabine and Schön, Gerhard and Neu, Johanna and Pantel, Klaus and Assmann, Volker},
  title = {The activity of the EMT suppressor GRHL2 is regulated by SUMOylation},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110662}
}
Kostenlos starten →